On April 2, 2026, ABIVAX Société Anonyme appointed Michael Nesrallah as Chief Commercial Officer. He will lead the company's global commercial strategy and launch preparation for obefazimod, capitalizing on his extensive biopharmaceutical experience.
Company Information
Company
Abivax
Location
Rue De La Baume
Paris, Ile-de-France, France
About
Abivax is developing therapies that modulate the body’s natural immune system machinery. A clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to develop drug candidates to treat inflammatory diseases, viral diseases and liver cancer. Abivax is based on innovative research driven by the idea of modulating the body’s natural immune system mechanisms to treat diseases.
Fundz sees it the moment Abivax changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ParisBiotechnologyHealth CareMedicalTherapeuticsPharmaceuticalConsultingLegalBiopharma